• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从蛋白激酶 PYK2 上模拟配体解离动力学。

Simulation of ligand dissociation kinetics from the protein kinase PYK2.

机构信息

Department of Chemistry and Biochemistry, University of Missouri-St. Louis, St. Louis, Missouri, USA.

Department of Mathematics and Computer Science, Freie Universität Berlin, Berlin, Germany.

出版信息

J Comput Chem. 2022 Oct 30;43(28):1911-1922. doi: 10.1002/jcc.26991. Epub 2022 Sep 8.

DOI:10.1002/jcc.26991
PMID:36073605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9976590/
Abstract

Early-stage drug discovery projects often focus on equilibrium binding affinity to the target alongside selectivity and other pharmaceutical properties. The kinetics of drug binding are ignored but can have significant influence on drug efficacy. Therefore, increasing attention has been paid on evaluating drug-binding kinetics early in a drug discovery process. Simulating drug-binding kinetics at the atomic level is challenging for the long time scale involved. Here, we used the transition-based reweighting analysis method (TRAM) with the Markov state model to study the dissociation of a ligand from the protein kinase PYK2. TRAM combines biased and unbiased simulations to reduce computational costs. This work used the umbrella sampling technique for the biased simulations. Although using the potential of mean force from umbrella sampling simulations with the transition-state theory over-estimated the dissociation rate by three orders of magnitude, TRAM gave a dissociation rate within an order of magnitude of the experimental value.

摘要

早期药物发现项目通常侧重于平衡结合亲和力与目标物,同时还考虑选择性和其他药物特性。药物结合的动力学通常被忽略,但它可能对药物疗效产生重大影响。因此,人们越来越关注在药物发现过程的早期评估药物结合动力学。在原子水平上模拟药物结合动力学具有挑战性,因为涉及到的时间尺度很长。在这里,我们使用基于跃迁的重新加权分析方法 (TRAM) 和马尔可夫状态模型来研究配体从蛋白激酶 PYK2 上的解离。TRAM 结合了有偏和无偏模拟以降低计算成本。这项工作使用了有偏模拟的伞状取样技术。尽管使用过渡态理论从伞状取样模拟中获取平均力势会高估解离速率三个数量级,但 TRAM 的解离速率与实验值相差一个数量级。

相似文献

1
Simulation of ligand dissociation kinetics from the protein kinase PYK2.从蛋白激酶 PYK2 上模拟配体解离动力学。
J Comput Chem. 2022 Oct 30;43(28):1911-1922. doi: 10.1002/jcc.26991. Epub 2022 Sep 8.
2
Quantitative Prediction of Dissociation Rates of PYK2 Ligands Using Umbrella Sampling and Milestoning.使用伞状采样和里程碑方法定量预测 PYK2 配体的离解速率。
J Chem Theory Comput. 2024 May 14;20(9):4029-4044. doi: 10.1021/acs.jctc.4c00192. Epub 2024 Apr 19.
3
Qualitative Prediction of Ligand Dissociation Kinetics from Focal Adhesion Kinase Using Steered Molecular Dynamics.使用引导分子动力学对粘着斑激酶配体解离动力学进行定性预测。
Life (Basel). 2021 Jan 20;11(2):74. doi: 10.3390/life11020074.
4
Multiensemble Markov models of molecular thermodynamics and kinetics.分子热力学与动力学的多系综马尔可夫模型
Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):E3221-30. doi: 10.1073/pnas.1525092113. Epub 2016 May 25.
5
Estimation of binding rates and affinities from multiensemble Markov models and ligand decoupling.从多总体 Markov 模型和配体去耦估计结合率和亲和力。
J Chem Phys. 2022 Apr 7;156(13):134115. doi: 10.1063/5.0088024.
6
15 Years of molecular simulation of drug-binding kinetics.药物结合动力学的 15 年分子模拟。
Expert Opin Drug Discov. 2023 Jul-Dec;18(12):1333-1348. doi: 10.1080/17460441.2023.2264770. Epub 2023 Nov 1.
7
Milestoning simulation of ligand dissociation from the glycogen synthase kinase 3β.里程碑式模拟配体从糖原合酶激酶 3β上的解离。
Proteins. 2023 Feb;91(2):209-217. doi: 10.1002/prot.26423. Epub 2022 Sep 24.
8
An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2.一项计算机高通量筛选鉴定出非受体酪氨酸激酶Pyk2的潜在选择性抑制剂。
Drug Des Devel Ther. 2017 May 18;11:1535-1557. doi: 10.2147/DDDT.S136150. eCollection 2017.
9
G Protein-Coupled Receptor-Ligand Dissociation Rates and Mechanisms from τRAMD Simulations.G 蛋白偶联受体-配体解离速率及 τRAMD 模拟机制。
J Chem Theory Comput. 2021 Oct 12;17(10):6610-6623. doi: 10.1021/acs.jctc.1c00641. Epub 2021 Sep 8.
10
Can One Trust Kinetic and Thermodynamic Observables from Biased Metadynamics Simulations?: Detailed Quantitative Benchmarks on Millimolar Drug Fragment Dissociation.从有偏差的元动力学模拟中能否信任动力学和热力学观测值?:毫摩尔药物片段离解的详细定量基准。
J Phys Chem B. 2019 May 2;123(17):3672-3678. doi: 10.1021/acs.jpcb.9b01813. Epub 2019 Apr 22.

引用本文的文献

1
CoVAMPnet: Comparative Markov State Analysis for Studying Effects of Drug Candidates on Disordered Biomolecules.CoVAMPnet:用于研究候选药物对无序生物分子影响的比较马尔可夫状态分析
JACS Au. 2024 May 28;4(6):2228-2245. doi: 10.1021/jacsau.4c00182. eCollection 2024 Jun 24.
2
Quantitative Prediction of Dissociation Rates of PYK2 Ligands Using Umbrella Sampling and Milestoning.使用伞状采样和里程碑方法定量预测 PYK2 配体的离解速率。
J Chem Theory Comput. 2024 May 14;20(9):4029-4044. doi: 10.1021/acs.jctc.4c00192. Epub 2024 Apr 19.
3
Characterization of binding kinetics and intracellular signaling of new psychoactive substances targeting cannabinoid receptor using transition-based reweighting method.使用基于转变的重加权方法对靶向大麻素受体的新型精神活性物质的结合动力学和细胞内信号传导进行表征。
bioRxiv. 2024 Apr 14:2023.09.29.560261. doi: 10.1101/2023.09.29.560261.
4
15 Years of molecular simulation of drug-binding kinetics.药物结合动力学的 15 年分子模拟。
Expert Opin Drug Discov. 2023 Jul-Dec;18(12):1333-1348. doi: 10.1080/17460441.2023.2264770. Epub 2023 Nov 1.
5
Selectivity and Ranking of Tight-Binding JAK-STAT Inhibitors Using Markovian Milestoning with Voronoi Tessellations.使用 Markovian Milestoning 与 Voronoi Tessellations 对紧密结合的 JAK-STAT 抑制剂进行选择性和排序。
J Chem Inf Model. 2023 Apr 24;63(8):2469-2482. doi: 10.1021/acs.jcim.2c01589. Epub 2023 Apr 6.
6
Quality over quantity: Sampling high probability rare events with the weighted ensemble algorithm.质量优于数量:使用加权集成算法对高概率稀有事件进行采样。
J Comput Chem. 2023 Mar 30;44(8):935-947. doi: 10.1002/jcc.27054. Epub 2022 Dec 13.

本文引用的文献

1
Combined Free-Energy Calculation and Machine Learning Methods for Understanding Ligand Unbinding Kinetics.联合自由能计算和机器学习方法以理解配体解吸动力学。
J Chem Theory Comput. 2022 Apr 12;18(4):2543-2555. doi: 10.1021/acs.jctc.1c00924. Epub 2022 Feb 23.
2
Computer Simulations of the Dissociation Mechanism of Gleevec from Abl Kinase with Milestoning.基于 Milestoning 的格列卫从 Abl 激酶中解离机制的计算机模拟。
J Phys Chem B. 2021 Jun 10;125(22):5706-5715. doi: 10.1021/acs.jpcb.1c00264. Epub 2021 Apr 30.
3
Solution-State Preorganization of Cyclic β-Hairpin Ligands Determines Binding Mechanism and Affinities for MDM2.溶液态中环 β-发夹配体的预组织决定了与 MDM2 的结合机制和亲和力。
J Chem Inf Model. 2021 May 24;61(5):2353-2367. doi: 10.1021/acs.jcim.1c00029. Epub 2021 Apr 27.
4
Qualitative Prediction of Ligand Dissociation Kinetics from Focal Adhesion Kinase Using Steered Molecular Dynamics.使用引导分子动力学对粘着斑激酶配体解离动力学进行定性预测。
Life (Basel). 2021 Jan 20;11(2):74. doi: 10.3390/life11020074.
5
Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2.结构-动力学关系揭示了 FAK 抑制剂对 PYK2 选择性的机制。
Cell Chem Biol. 2021 May 20;28(5):686-698.e7. doi: 10.1016/j.chembiol.2021.01.003. Epub 2021 Jan 25.
6
Recent progress in molecular simulation methods for drug binding kinetics.药物结合动力学的分子模拟方法的最新进展。
Curr Opin Struct Biol. 2020 Oct;64:126-133. doi: 10.1016/j.sbi.2020.06.022. Epub 2020 Aug 6.
7
REVO: Resampling of ensembles by variation optimization.REVO:通过变异优化对集成进行重采样。
J Chem Phys. 2019 Jun 28;150(24):244112. doi: 10.1063/1.5100521.
8
Defining a new nomenclature for the structures of active and inactive kinases.定义活性和非活性激酶结构的新命名法。
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6818-6827. doi: 10.1073/pnas.1814279116. Epub 2019 Mar 13.
9
Predicting ligand binding affinity using on- and off-rates for the SAMPL6 SAMPLing challenge.使用 SAMPL6 SAMPLing 挑战的结合和解离速率预测配体结合亲和力。
J Comput Aided Mol Des. 2018 Oct;32(10):1001-1012. doi: 10.1007/s10822-018-0149-3. Epub 2018 Aug 23.
10
Estimation of Drug-Target Residence Times by τ-Random Acceleration Molecular Dynamics Simulations.τ-随机加速分子动力学模拟估算药物-靶标停留时间。
J Chem Theory Comput. 2018 Jul 10;14(7):3859-3869. doi: 10.1021/acs.jctc.8b00230. Epub 2018 Jun 4.